عنوان مقاله [English]
نویسندگان [English]چکیده [English]
Hormonal contraceptives are currently available in oral, injectable, transdermal patch and transvaginal-ring forms. Combination oral contraceptives (COCs) are the most frequently used method of hormonal contraception and an almost bewildering variety that are available. A onceandndash;a-month injectable contraception was briefly available. Monthly withdrawal bleeding is similar to a normal menses, leading to high continuation rates despite the need for a monthly injection.This presentstudy is a clinical trial due to aim. Overall; women in need of contraception were recruited after signing an informed consent form in Shiraz health clinics. Women who were with the same partner throughout the study period were randomized to one of 2 treatment groups. We were collected data by questionnaire through personal interview, observation and measurements with 97 women for 4 months. Statistical analyses were performed on both groups. Data were collected and analyzed descriptive, independent T test and chi square by SPSS software. Our findings revealed that both drugs had the capacity to decrease length of menstrual bleeding, where as there is no significant difference between two groups. Both drugs had the capacity to decrease amount of bleeding, whereas there is no significant difference between two groups. . Both drugs had the capacity to decrease dysmenorhea, where as there is no significant difference between two groups. There is no finding significant increase in spotting or breakthrough bleeding and amenorrhea in both groups.In conclusion, the present study showed that cyclofem is a valid contraceptive method to ensure optimal cycle control with low hormonal doses monthly administration and good cycle control make this contraceptive an alternative to combined oral contraceptives, avoiding the necessity of taking medication on daily basis.